|
Market Closed -
Deutsche Boerse AG
03:55:01 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 0.6158 EUR | -5.87% |
|
-17.34% | +8.04% |
| 09-07 | CStone Pharmaceuticals Joins Stock Connect Southbound Trading | MT |
| 08-31 | Cstone Pharmaceuticals Provides Updates on Cs2009 and Pipeline 2.0 Clinical Trials and Product Portfolio | CI |
Company Valuation: CStone Pharmaceuticals
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,845 | 4,882 | 2,628 | 2,759 | 6,980 | 7,888 | - | - |
| Change | - | -37.77% | -46.18% | 4.99% | 153.01% | 13.01% | - | - |
| Enterprise Value (EV) 1 | 7,249 | 4,551 | 1,950 | 2,404 | 6,404 | 6,911 | 3,866 | 3,716 |
| Change | - | -37.22% | -57.15% | 23.28% | 166.37% | 7.91% | -44.06% | -3.86% |
| P/E | - | -5.32x | -7.11x | -30.9x | -15.3x | -17.1x | 8.29x | -99x |
| PBR | 6.63x | 10.9x | 5.7x | - | 10.7x | - | - | - |
| PEG | - | - | 0.1x | 0.4x | -0x | 2.65x | -0x | 1x |
| Capitalization / Revenue | 32.2x | 10.1x | 5.67x | 6.78x | 25.9x | 18.6x | 4.58x | 8.25x |
| EV / Revenue | 29.7x | 9.45x | 4.2x | 5.9x | 23.8x | 16.3x | 2.24x | 3.89x |
| EV / EBITDA | -3.99x | -5.1x | -3.33x | -25.9x | -16.5x | -17.1x | 2x | 17.5x |
| EV / EBIT | -3.96x | -4.99x | -3.22x | -22.7x | -14.8x | -18.1x | 3.51x | -47.3x |
| EV / FCF | -4.57x | -7.43x | - | - | -19.5x | -22x | -19.5x | -30.2x |
| FCF Yield | -21.9% | -13.5% | - | - | -5.12% | -4.54% | -5.12% | -3.31% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | -0.77 | -0.29 | -0.07 | -0.31 | -0.29 | 0.5967 | -0.05 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 243.7 | 481.4 | 463.8 | 407.2 | 269.6 | 423.2 | 1,722 | 956.2 |
| EBITDA 1 | -1,818 | -892.9 | -585.4 | -92.72 | -388.6 | -405.2 | 1,937 | 212.3 |
| EBIT 1 | -1,829 | -912.1 | -605.6 | -106.1 | -432.6 | -381 | 1,102 | -78.51 |
| Net income 1 | -1,920 | -902.7 | -367.2 | -91.21 | -437 | -383.5 | 680.5 | -48.57 |
| Net Debt 1 | -596.2 | -331.1 | -677.7 | -354.7 | -576.3 | -977.7 | -4,023 | -4,172 |
| Reference price 2 | 6.737 | 4.096 | 2.061 | 2.161 | 4.736 | 4.948 | 4.948 | 4.948 |
| Nbr of stocks (in thousands) | 1,164,452 | 1,192,099 | 1,275,317 | 1,276,503 | 1,473,942 | 1,594,112 | - | - |
| Announcement Date | 6/8/22 | 4/26/23 | 4/23/24 | 3/27/25 | 3/26/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 18.1x | 4.19x | 9.84x | 0.5% | 78.02B | |
| -17.17x | 25.62x | -16.63x | -.--% | 57.48B | |
| 19.65x | 4.21x | 13.08x | 2.5% | 57.4B | |
| 34.47x | 11.73x | 22.49x | -.--% | 48.81B | |
| 20.54x | 4.54x | 12.95x | 0.71% | 45.5B | |
| 37.49x | 3.54x | 13.51x | -.--% | 32.08B | |
| 54.21x | 3.43x | 26.59x | -.--% | 24.62B | |
| 62.21x | 6.52x | 39.5x | -.--% | 20.77B | |
| 22.98x | 4.94x | 12.86x | -.--% | 15.75B | |
| Average | 28.05x | 7.64x | 14.91x | 0.41% | 42.27B | |
| Weighted average by Cap. | 21.98x | 8.49x | 11.46x | 0.56% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
- Valuation CStone Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
